| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A Dynamical Systems Analysis of the Indirect Response Model with Special Emphasis on Time to Peak Response
|
Peletier, Lambertus A.
|
|
2005
|
32 |
3-4 |
p. 607-654
|
artikel
|
| 2 |
A Dynamical Systems Analysis of the Indirect Response Model with Special Emphasis on Time to Peak Response
|
Peletier, Lambertus A.
|
|
2005
|
32 |
3-4 |
p. 607-654
|
artikel
|
| 3 |
Cluster Analysis: An Alternative Method for Covariate Selection in population Pharmacokinetic Modeling
|
Semmar, Nabil
|
|
2005
|
32 |
3-4 |
p. 333-358
|
artikel
|
| 4 |
Cluster Analysis: An Alternative Method for Covariate Selection in population Pharmacokinetic Modeling
|
Semmar, Nabil
|
|
2005
|
32 |
3-4 |
p. 333-358
|
artikel
|
| 5 |
Collapsing Mechanistic Models: An Application to Dose Selection for Proof of Concept of a Selective Irreversible Antagonist
|
Hutmacher, Matthew M.
|
|
2005
|
32 |
3-4 |
p. 501-520
|
artikel
|
| 6 |
Collapsing Mechanistic Models: An Application to Dose Selection for Proof of Concept of a Selective Irreversible Antagonist
|
Hutmacher, Matthew M.
|
|
2005
|
32 |
3-4 |
p. 501-520
|
artikel
|
| 7 |
Importance of Within Subject Variation in Levodopa Pharmacokinetics: A 4Year Cohort Study in Parkinson’s Disease
|
Chan, Phylinda L. S.
|
|
2005
|
32 |
3-4 |
p. 307-331
|
artikel
|
| 8 |
Importance of Within Subject Variation in Levodopa Pharmacokinetics: A 4Year Cohort Study in Parkinson’s Disease
|
Chan, Phylinda L. S.
|
|
2005
|
32 |
3-4 |
p. 307-331
|
artikel
|
| 9 |
Optimal Design for Model Discrimination and Parameter Estimation for Itraconazole Population Pharmacokinetics in Cystic Fibrosis Patients
|
Waterhouse, Timothy H.
|
|
2005
|
32 |
3-4 |
p. 521-545
|
artikel
|
| 10 |
Optimal Design for Model Discrimination and Parameter Estimation for Itraconazole Population Pharmacokinetics in Cystic Fibrosis Patients
|
Waterhouse, Timothy H.
|
|
2005
|
32 |
3-4 |
p. 521-545
|
artikel
|
| 11 |
Pharmacodynamic Analysis of Changes in Reticulocyte Subtype Distribution in Phlebotomy-Induced Stress Erythropoiesis
|
Al-Huniti, Nidal H.
|
|
2005
|
32 |
3-4 |
p. 359-376
|
artikel
|
| 12 |
Pharmacokinetic and Pharmacodynamic Changes During the First Four Years of Levodopa Treatment in Parkinson’s Disease
|
Chan, Phylinda L. S.
|
|
2005
|
32 |
3-4 |
p. 459-484
|
artikel
|
| 13 |
Pharmacokinetic and Pharmacodynamic Changes During the First Four Years of Levodopa Treatment in Parkinson’s Disease
|
Chan, Phylinda L. S.
|
|
2005
|
32 |
3-4 |
p. 459-484
|
artikel
|
| 14 |
Population Pharmacokinetic–Pharmacodynamic Modeling of Subcutaneous and Pulmonary Insulin in Rats
|
Gopalakrishnan, Mathangi
|
|
2005
|
32 |
3-4 |
p. 485-500
|
artikel
|
| 15 |
Population Pharmacokinetics of the Active Metabolite of Leflunomide in Pediatric Subjects with Polyarticular Course Juvenile Rheumatoid Arthritis
|
Shi, Jun
|
|
2005
|
32 |
3-4 |
p. 419-439
|
artikel
|
| 16 |
Population Pharmacokinetics of the Active Metabolite of Leflunomide in Pediatric Subjects with Polyarticular Course Juvenile Rheumatoid Arthritis
|
Shi, Jun
|
|
2005
|
32 |
3-4 |
p. 419-439
|
artikel
|
| 17 |
Propagation of Population Pharmacokinetic Information Using a Bayesian Approach: Comparison with Meta-Analysis
|
Dokoumetzidis, Aristides
|
|
2005
|
32 |
3-4 |
p. 401-418
|
artikel
|
| 18 |
Propagation of Population Pharmacokinetic Information Using a Bayesian Approach: Comparison with Meta-Analysis
|
Dokoumetzidis, Aristides
|
|
2005
|
32 |
3-4 |
p. 401-418
|
artikel
|
| 19 |
Some Considerations on the Design of Population Pharmacokinetic Studies
|
Duffull, Stephen
|
|
2005
|
32 |
3-4 |
p. 441-457
|
artikel
|
| 20 |
Some Considerations on the Design of Population Pharmacokinetic Studies
|
Duffull, Stephen
|
|
2005
|
32 |
3-4 |
p. 441-457
|
artikel
|
| 21 |
The Acute Disposition of (R)- and (S)-Methadone in Brain and Lung of Sheep
|
Foster, David J. R.
|
|
2005
|
32 |
3-4 |
p. 547-570
|
artikel
|
| 22 |
The Acute Disposition of (R)- and (S)-Methadone in Brain and Lung of Sheep
|
Foster, David J. R.
|
|
2005
|
32 |
3-4 |
p. 547-570
|
artikel
|
| 23 |
The Population Pharmacokinetics of Citalopram After Deliberate Self-Poisoning: A Bayesian Approach
|
Friberg, Lena E.
|
|
2005
|
32 |
3-4 |
p. 571-605
|
artikel
|
| 24 |
The Population Pharmacokinetics of Citalopram After DeliberateSelf-Poisoning: A Bayesian Approach
|
Friberg, Lena E.
|
|
2005
|
32 |
3-4 |
p. 571-605
|
artikel
|
| 25 |
Unified Pharmacogenetics-Based Parent–Metabolite Pharmacokinetic Model Incorporating Acetylation Polymorphism for Talampanel in Humans
|
Buchwald, Peter
|
|
2005
|
32 |
3-4 |
p. 377-400
|
artikel
|
Tijdschrift beschrijving